Other Names for this Disease
- Urachal carcinoma
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Surgical resection in the form of partial (segmental) or radical cystoprostatectomy is the main form of treatment. However, similar results are seen with a conservative surgery that involves partial cystectomy with umbilicotomy and removal of the urachus. The role of chemotherapy and radiation therapy for the treatment of urachal cancer is unclear, although some studies show that chemotherapy can induce objective response in some cases. Chemotherapy regimens that may be used include: single-agent 5-fluorouracil (5-FU), 5-FU and cisplatin, 5-FU, lomustine and vincristine, taxol and cisplatin, platinum and etoposide, and MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) alone or in conjunction with radiation therapy.
Last updated: 12/16/2009
- Molina JR, Quevedo JF, Furth AF, Richardson RL, Zincke H, Burch PA. 2007; http://onlinelibrary.wiley.com/doi/10.1002/cncr.23070/full. Accessed 12/16/2009.
- Jankowski JT, Cherullo EE, Steinway ML, Feng AH. Cystectomy, Partial. eMedicine. 2008; http://emedicine.medscape.com/article/446101-overview. Accessed 12/16/2009.
- ClinicalTrials.gov lists trials that are studying or have studied Urachal cancer. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.